Investing.com -- MaaT Pharma has unveiled its financial results for fiscal year 2024 (FY24), reporting a revenue of €3.2m, a 44% increase from 2023. This surge in revenue is largely attributed to an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback